Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Quoin Pharmaceuticals Ltd ADR shares valued at $250,000 were purchased by Carter Denise P. on Dec 23 ’24. At $0.45 per share, Carter Denise P. acquired 555,556 shares. The insider’s holdings grew to 602,648 shares worth approximately $0.22 million following the completion of this transaction.
Also, Myers Michael purchased 555,556 shares, netting a total of over 250,000 in proceeds. Following the buying of shares at $0.45 each, the insider now holds 602,808 shares.
Before that, Dunn Gordon had added 122,221 shares to its account. In a trade valued at $54,999, the Chief Financial Officer bought Quoin Pharmaceuticals Ltd ADR shares for $0.45 each. Upon closing the transaction, the insider’s holdings increased to 122,221 shares, worth approximately $54387.72.
Analyzing QNRX Stock Performance
During the last five days, there has been a surge of approximately 6.73%. Over the course of the year, Quoin Pharmaceuticals Ltd ADR shares have dropped approximately -45.41%. Shares of the company reached a 52-week high of $0.8100 on 01/03/25 and a 52-week low of $0.2811 on 01/30/25. A 50-day SMA is recorded $0.4650, while a 200-day SMA reached $0.6025.
Support And Resistance Levels for Quoin Pharmaceuticals Ltd ADR (QNRX)
According to the 24-hour chart, there is a support level at 0.2954, which, if violated, would cause prices to drop to 0.2356. In the upper region, resistance lies at 0.4425. The next price resistance is at 0.5298. RSI (Relative Strength Index) is 47.58 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0065, which suggests the price will decrease in the coming days. Percent R is at 63.78%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
